Synovial mesenchymal stem cells from osteo- or rheumatoid arthritis joints exhibit good potential for cartilage repair using a scaffold-free tissue engineering approach.

OBJECTIVE To assess whether synovial mesenchymal stem cells (SMSCs) from patients with osteoarthritis (OA) or rheumatoid arthritis (RA) can be used as an alternative cell source for cartilage repair using allogenic tissue engineered construct (TEC). METHODS Twenty-five patients (17 female, average age 61.8 years) were divided according to their pathology (control trauma group; N = 6, OA group; N = 6) and RA patients were subdivided into two groups to evaluate the impact of biologics in accordance with whether treated with biologics [Bio(+)RA; N = 7] or not [Bio(-)RA; N = 6]. We compared the following characteristics among these groups: (1) The cell proliferation capacity of SMSCs; (2) The influence of passage number on features of SMSCs; (3) The weight and volume of TEC from the same number of SMSCs; (4) Inflammatory cytokine gene expressions levels of TEC; (5) The chondrogenic potential of TEC; and (6) Osteochondral repair using TEC in athymic nude rats. RESULTS SMSCs from the four groups exhibited equivalent features in the above evaluation items. In in vivo studies, the TEC-treated repair tissues for all groups exhibited significantly better outcomes than those for the untreated group and no significant differences among the four TEC groups. CONCLUSION SMSCs from OA or RA patients are no less appropriate for repairing cartilage than those from trauma patients and thus, may be an effective source for allogenic cell-based cartilage repair.

[1]  H. Shim,et al.  Intra‐Articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A Proof‐of‐Concept Clinical Trial , 2014, Stem cells.

[2]  J. Pelletier,et al.  Interleukin-1beta-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1beta and interleukin-18. , 1999, Arthritis and rheumatism.

[3]  Shigeyuki Wakitani,et al.  Autologous Bone Marrow Stromal Cell Transplantation for Repair of Full-Thickness Articular Cartilage Defects in Human Patellae: Two Case Reports , 2004, Cell transplantation.

[4]  J. Jorquera,et al.  Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools , 2015, Stem Cell Research & Therapy.

[5]  D. Hart,et al.  In vitro generation of a scaffold-free tissue-engineered construct (TEC) derived from human synovial mesenchymal stem cells: biological and mechanical properties and further chondrogenic potential. , 2008, Tissue engineering. Part A.

[6]  Joseph M. Mansour,et al.  Mesenchymal Cell-Based Repair of Large Full Thickness Defects of Articular Cartilage , 1994 .

[7]  R. Kandel,et al.  A New Histology Scoring System for the Assessment of the Quality of Human Cartilage Repair: ICRS II , 2010, The American journal of sports medicine.

[8]  G. Schulze-Tanzil,et al.  The Influence of IL-10 and TNFα on Chondrogenesis of Human Mesenchymal Stromal Cells in Three-Dimensional Cultures , 2014, International journal of molecular sciences.

[9]  P. Emery,et al.  Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level , 2009, Annals of the rheumatic diseases.

[10]  C. Pilapil,et al.  Interleukin‐1β and tumor necrosis factor α inhibit chondrogenesis by human mesenchymal stem cells through NF‐κB–dependent pathways , 2009 .

[11]  T. Matsushita,et al.  Therapeutic strategy of third-generation autologous chondrocyte implantation for osteoarthritis , 2011, Upsala journal of medical sciences.

[12]  D. Hart,et al.  Repair of meniscal lesions using a scaffold-free tissue-engineered construct derived from allogenic synovial MSCs in a miniature swine model. , 2013, Biomaterials.

[13]  A. Caplan,et al.  Low oxygen tension during incubation periods of chondrocyte expansion is sufficient to enhance postexpansion chondrogenesis. , 2010, Tissue engineering. Part A.

[14]  P. Müller,et al.  Analysis of the autologous chondrocyte quality of matrix-based autologous chondrocyte implantation in the knee joint , 2015, International Orthopaedics.

[15]  E B Hunziker,et al.  Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. , 2002, Osteoarthritis and cartilage.

[16]  B. Moretti,et al.  Role of cytokines in gonarthrosis and knee prosthesis aseptic loosening , 2004, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[17]  I. Rasmusson.  Immune modulation by mesenchymal stem cells. , 2006, Experimental cell research.

[18]  Xiaolong Deng,et al.  The role of IL-6 in bone marrow (BM)-derived mesenchymal stem cells (MSCs) proliferation and chondrogenesis , 2013, Cell and Tissue Banking.

[19]  M. Scott,et al.  Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration , 2006, Proceedings of the National Academy of Sciences.

[20]  D. Hart,et al.  Comparison of Human Serum with Fetal Bovine Serum for Expansion and Differentiation of Human Synovial MSC: Potential Feasibility for Clinical Applications , 2008, Cell transplantation.

[21]  I. Matsumoto,et al.  Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept , 2016, Modern rheumatology.

[22]  C. Frank,et al.  Changes of early post-traumatic osteoarthritis in an ovine model of simulated ACL reconstruction are associated with transient acute post-injury synovial inflammation and tissue catabolism. , 2013, Osteoarthritis and cartilage.

[23]  P. Kämmerer,et al.  The influence of bone marrow‐ and synovium‐derived mesenchymal stromal cells from osteoarthritis patients on regulatory T cells in co‐culture , 2013, Clinical and experimental immunology.

[24]  Daniel A Grande,et al.  Articular Cartilage Repair , 2013, Cartilage.

[25]  F. Luyten,et al.  Multipotent mesenchymal stem cells from adult human synovial membrane. , 2001, Arthritis and rheumatism.

[26]  R. Krawetz,et al.  Increased levels of p21(CIP1/WAF1) correlate with decreased chondrogenic differentiation potential in synovial membrane progenitor cells. , 2015, Mechanisms of Ageing and Development.

[27]  M. Kashiwagi,et al.  Aggrecanases and cartilage matrix degradation , 2003, Arthritis research & therapy.

[28]  C. Bari.  Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys , 2015 .

[29]  Hiromichi Fujie,et al.  Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. , 2007, Biomaterials.

[30]  P. Miossec.  The role of interleukin 1 in the pathogenesis of rheumatoid arthritis. , 1987, Clinical and experimental rheumatology.

[31]  H. Roos,et al.  Temporal patterns of stromelysin‐1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus , 1994, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[32]  Rui Yang,et al.  Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis , 2013, Arthritis Research & Therapy.

[33]  D. Hart,et al.  The influence of skeletal maturity on allogenic synovial mesenchymal stem cell-based repair of cartilage in a large animal model. , 2010, Biomaterials.

[34]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[35]  ShimomuraKazunori,et al.  Osteochondral Repair Using a Scaffold-Free Tissue-Engineered Construct Derived from Synovial Mesenchymal Stem Cells and a Hydroxyapatite-Based Artificial Bone , 2014 .

[36]  Hao Tang,et al.  YKL-40 Induces IL-8 Expression from Bronchial Epithelium via MAPK (JNK and ERK) and NF-κB Pathways, Causing Bronchial Smooth Muscle Proliferation and Migration , 2012, The Journal of Immunology.

[37]  D. Hart,et al.  Detection of abnormalities in the superficial zone of cartilage repaired using a tissue engineered construct derived from synovial stem cells. , 2012, European cells & materials.

[38]  D. Hart.  Why Mesenchymal Stem/Progenitor Cell Heterogeneity in Specific Environments? —Implications for Tissue Engineering Applications Following Injury or Degeneration of Connective Tissues , 2014 .

[39]  S. Kuzmanova.  Treatment of knee osteoarthritis by arthroscopic synovectomy and debridement of cartilage lesions--late results. , 2003, Folia medica.

[40]  K. Goto,et al.  Scoring evaluation for histopathological features of synovium in patients with rheumatoid arthritis during anti-tumor necrosis factor therapy , 2009, Rheumatology International.

[41]  E. Jones,et al.  Mesenchymal stem cells, autoimmunity and rheumatoid arthritis , 2014, QJM : monthly journal of the Association of Physicians.

[42]  M. Bigoni,et al.  Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[43]  C. Mcewen.  Multicenter evaluation of synovectomy in the treatment of rheumatoid arthritis. Report of results at the end of five years. , 1988, The Journal of rheumatology.

[44]  M. Feldmann,et al.  Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis , 1991, Rheumatology International.

[45]  C. Frank,et al.  Ovine synovial membrane-derived mesenchymal progenitor cells retain the phenotype of the original tissue that was exposed to in-vivo inflammation: evidence for a suppressed chondrogenic differentiation potential of the cells , 2012, Inflammation Research.

[46]  L. Davis,et al.  Elevated interleukin-10 levels in patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[47]  N. Ashammakhi,et al.  Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms. , 2008, Regenerative medicine.